Products
Phenolate-s™ Tablets
Composition
Phenolate s™ 180: Each enteric coated tablet contains
Mycophenolic acid (as sodium salt)              180mg
Phenolate s™ 360: Each enteric coated tablet contains
Mycophenolic acid (as sodium salt)              360mg
Indications
Phenolate s™ delayed release tablets are indicated for the prophylaxis of organ rejection in patients receiving allogeneic renal transplants, administered in combination with cyclosporine and corticosteroids.
Storage & handling instructions
Store at a temperature not more than 30C, protect from light and moisture, keep out of reach of children.
Shelf life:
24 months from the date of manufacturing.
Packaging information:
Blister strip of 6 x 10 tablets